Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

4 Citations (Scopus)

Abstract

Fibromyalgia (FM) syndrome is a common chronic pain syndrome with predictable clinical features that result from altered neurophysiological functions of the pain-related nervous system. Relevant mechanisms range from sensitization within the brain and spinal cord to augmented peripheral mechanoreceptor inputs, leading to pain and tenderness. The clinical picture may be seen as a final common pathway resulting from a range of inputs that vary between individuals. Subgroups of FM may reflect these inputs. There are many factors that increase vulnerability to FM, in particular gender and age. The majority of patients can identify a trigger that precedes development of the syndrome. Many triggers relate to a precipitating event that associates with psychological distress, often acting on a longer-term background of life-stress. Reactions to life predicaments, involving coping skills, may act as factors that promote ongoing sensitization. Genetic variability in a number of pain-related chemicals might also modulate the response of the pain system to any given input. Of particular interest are those that relate to the mono-amines serotonin, norepinephrine, and dopamine. Better clinical characterization of large cohorts of FM patients will enhance the value of techniques such as single nucleotide polypeptide analysis. Further knowledge of factors increasing vulnerability to FM will allow for early intervention and improve outcomes of this high-impact disorder.

Original languageEnglish
Title of host publicationMuscle Pain
Subtitle of host publicationDiagnosis and Treatment
PublisherSpringer-Verlag London Ltd.
Pages143-157
Number of pages15
ISBN (Electronic)9783642054686
ISBN (Print)9783642054679
DOIs
Publication statusPublished - 1 Jan 2010

Keywords

  • Coping skills
  • Fibromyalgia
  • Gender
  • Genetic variability
  • Psychological distress
  • Risk factors
  • Single nucleotide polypeptide analysis
  • Subgroups

Cite this

Littlejohn, G. O. (2010). Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia. In Muscle Pain: Diagnosis and Treatment (pp. 143-157). Springer-Verlag London Ltd.. https://doi.org/10.1007/978-3-642-05468-6_5
Littlejohn, Geoffrey O. / Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia. Muscle Pain: Diagnosis and Treatment. Springer-Verlag London Ltd., 2010. pp. 143-157
@inbook{405ae27b3efc48a7b624cb8650b1eedc,
title = "Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia",
abstract = "Fibromyalgia (FM) syndrome is a common chronic pain syndrome with predictable clinical features that result from altered neurophysiological functions of the pain-related nervous system. Relevant mechanisms range from sensitization within the brain and spinal cord to augmented peripheral mechanoreceptor inputs, leading to pain and tenderness. The clinical picture may be seen as a final common pathway resulting from a range of inputs that vary between individuals. Subgroups of FM may reflect these inputs. There are many factors that increase vulnerability to FM, in particular gender and age. The majority of patients can identify a trigger that precedes development of the syndrome. Many triggers relate to a precipitating event that associates with psychological distress, often acting on a longer-term background of life-stress. Reactions to life predicaments, involving coping skills, may act as factors that promote ongoing sensitization. Genetic variability in a number of pain-related chemicals might also modulate the response of the pain system to any given input. Of particular interest are those that relate to the mono-amines serotonin, norepinephrine, and dopamine. Better clinical characterization of large cohorts of FM patients will enhance the value of techniques such as single nucleotide polypeptide analysis. Further knowledge of factors increasing vulnerability to FM will allow for early intervention and improve outcomes of this high-impact disorder.",
keywords = "Coping skills, Fibromyalgia, Gender, Genetic variability, Psychological distress, Risk factors, Single nucleotide polypeptide analysis, Subgroups",
author = "Littlejohn, {Geoffrey O.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1007/978-3-642-05468-6_5",
language = "English",
isbn = "9783642054679",
pages = "143--157",
booktitle = "Muscle Pain",
publisher = "Springer-Verlag London Ltd.",
address = "Germany",

}

Littlejohn, GO 2010, Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia. in Muscle Pain: Diagnosis and Treatment. Springer-Verlag London Ltd., pp. 143-157. https://doi.org/10.1007/978-3-642-05468-6_5

Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia. / Littlejohn, Geoffrey O.

Muscle Pain: Diagnosis and Treatment. Springer-Verlag London Ltd., 2010. p. 143-157.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia

AU - Littlejohn, Geoffrey O.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Fibromyalgia (FM) syndrome is a common chronic pain syndrome with predictable clinical features that result from altered neurophysiological functions of the pain-related nervous system. Relevant mechanisms range from sensitization within the brain and spinal cord to augmented peripheral mechanoreceptor inputs, leading to pain and tenderness. The clinical picture may be seen as a final common pathway resulting from a range of inputs that vary between individuals. Subgroups of FM may reflect these inputs. There are many factors that increase vulnerability to FM, in particular gender and age. The majority of patients can identify a trigger that precedes development of the syndrome. Many triggers relate to a precipitating event that associates with psychological distress, often acting on a longer-term background of life-stress. Reactions to life predicaments, involving coping skills, may act as factors that promote ongoing sensitization. Genetic variability in a number of pain-related chemicals might also modulate the response of the pain system to any given input. Of particular interest are those that relate to the mono-amines serotonin, norepinephrine, and dopamine. Better clinical characterization of large cohorts of FM patients will enhance the value of techniques such as single nucleotide polypeptide analysis. Further knowledge of factors increasing vulnerability to FM will allow for early intervention and improve outcomes of this high-impact disorder.

AB - Fibromyalgia (FM) syndrome is a common chronic pain syndrome with predictable clinical features that result from altered neurophysiological functions of the pain-related nervous system. Relevant mechanisms range from sensitization within the brain and spinal cord to augmented peripheral mechanoreceptor inputs, leading to pain and tenderness. The clinical picture may be seen as a final common pathway resulting from a range of inputs that vary between individuals. Subgroups of FM may reflect these inputs. There are many factors that increase vulnerability to FM, in particular gender and age. The majority of patients can identify a trigger that precedes development of the syndrome. Many triggers relate to a precipitating event that associates with psychological distress, often acting on a longer-term background of life-stress. Reactions to life predicaments, involving coping skills, may act as factors that promote ongoing sensitization. Genetic variability in a number of pain-related chemicals might also modulate the response of the pain system to any given input. Of particular interest are those that relate to the mono-amines serotonin, norepinephrine, and dopamine. Better clinical characterization of large cohorts of FM patients will enhance the value of techniques such as single nucleotide polypeptide analysis. Further knowledge of factors increasing vulnerability to FM will allow for early intervention and improve outcomes of this high-impact disorder.

KW - Coping skills

KW - Fibromyalgia

KW - Gender

KW - Genetic variability

KW - Psychological distress

KW - Risk factors

KW - Single nucleotide polypeptide analysis

KW - Subgroups

UR - http://www.scopus.com/inward/record.url?scp=84865287593&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-05468-6_5

DO - 10.1007/978-3-642-05468-6_5

M3 - Chapter (Book)

SN - 9783642054679

SP - 143

EP - 157

BT - Muscle Pain

PB - Springer-Verlag London Ltd.

ER -